Cancer Research Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine  Joint Metastasis Research Society-AACR Conference on Metastasis
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

[Cancer Research 30, 936-941, April 1, 1970]
© 1970 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ertürk, E.
Right arrow Articles by Bryan, G. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ertürk, E.
Right arrow Articles by Bryan, G. T.

Carcinogenicity of N-[4-(5-Nitro-2-furyl)-2-thiazolyl] acetamide in Female Rats1

E. Ertürk, S. M. Cohen2 and George T. Bryan3

The Division of Clinical Oncology, University of Wisconsin Medical School, Madison, Wisconsin 53706

N-[4-(5-Nitro-2-furyl)-2-thiazolyl] acetamide was fed to 70 female Sprague-Dawley weanling rats at a dosage of 0.199% by weight for 46 weeks, followed by 20 weeks of the control diet. Forty control rats received only ground diet for the entire 66 weeks. Rats were weighed and food consumption was determined biweekly at first and then monthly. With weekly palpation the first mammary tumor was detected at 16 weeks, and tumor incidences are based on the number of rats alive at this time. Every 1 or 2 weeks, 1 rat was sacrificed to determine any early pathological changes of the urinary tract or other internal organs.

Of the 56 rats that survived 16 or more weeks, 52 had tumors with the following organ distribution: 47 mammary tumors (24 fibroadenomas and 23 adenocarcinomas), 6 salivary gland adenocarcinomas, 7 alveolar cell carcinomas of the lung, 2 transitional cell carcinomas of the kidney, 3 skin tumors (squamous cell carcinoma, fibrosarcoma, mastocytoma), 1 small intestinal adenocarcinoma, and 1 splenic lymphosarcoma with hepatic metastases. A systemic lymphoreticular response involving the spleen and lymph nodes was seen in a majority of the rats, and several rats had edema, hemorrhage, and partial destruction of the adrenal gland. No tumors were found in the control rats.

A fibroadenoma, an adenofibroma, and an adenocarcinoma of mammary origin and an adenocarcinoma of salivary gland origin were transplantable to the subcutaneous tissue of female Sprague-Dawley weanling rats with the following incidences of transplantable tumors: 7/24, 4/12, 9/12, and 14/24, respectively. Two of the 9 mammary adenocarcinomas that grew in recipient rats metastasized: one through the abdominal wall and into the liver, the other to the spleen.

1 Supported in part by Grant CA-10017 from the National Cancer Institute and by a grant from the Wisconsin Division of the American Cancer Society.

2 Medical Scientist Trainee of the National Institute of General Medical Sciences (GM-01932).

3 Career Development Awardee of the National Cancer Institute (1-K4-CA-8245-01A1).

Received 6/ 6/69. Accepted 9/19/69.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 1970 by the American Association for Cancer Research.